Thus, RNA preparations from such samples would contain an excess of mRNA originating from RAI3-negative connective tissue, resulting in lower overall signal levels compared to the tumour samples, a phenomenon that could also have affected previous RNA-based studies of breast cancer. This evidence concerns the gene GPRC5A and breast cancer.